Indefinite Delivery Contract SPE2DR25D9301

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original solicitation, which DLA plans to issue in March 2024, seeks to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, DoD components, the U.S. Coast Guard, and the U.S. Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The solicitation is expected to be an unrestricted, fully competitive acquisition, with awards made on a regional basis to at least three different contractors across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items.